仿製藥 的英文怎麼說

中文拼音 [fǎngzhìyào]
仿製藥 英文
anda
  • 藥 : Ⅰ名詞1 （藥物） medicine; drug; remedy 2 （某些有化學作用的物質） certain chemicals Ⅱ動詞1 [書面...
  1. Including shotguns, air guns, humane killers, bolt guns, flare pistols and starting pistols, ammunition, replica or imitation firearms, cross bows

    ，包括獵槍氣槍動物屠宰機槍栓閃光信號槍發令槍彈藥槍械復製品或仿製品弩。
  2. So that japanese pharmaceutical enterprises could not copy the existed drugs any more, this situation is almost the same as what chinese pharmaceutical industry has been being faced with since 1 993 the protection of drug paten had been put into effect and china joined the wto

    特別是， 1976年日本由原來的製造法保護改變為藥品的專利保護，致使日本的醫藥產業面臨著無法繼續一貫的仿製藥品的生產路線的情況與我國1993年實施藥品專利保護和加入wto之後所面臨的情況基本一致。
  3. Hatchcosponsored legislation that speeds to market generic versions ofconventional drugs

    海契倡立了一個旨在加速銷售傳統藥品的仿製品的法規。
  4. But in myanmar msf has no access to abacavir as the drug is expensive and there are no low - cost prequalified generic versions

    但阿巴卡韋（ abacavir ）在緬甸的售價非常高，且沒有廉價的仿製配方，無國界醫生實在無法負擔高昂的藥費。
  5. Vietnam says it may produce a generic version of the antiviral drug tamiflu if a licensing agreement cannot be reached with the drug ' s swiss manufacturer ( roche holding ag )

    越南表示，如果不能和瑞士羅氏制藥公司達成生產「達菲」藥品協議的話，越南可能會自行生產抗禽流感病毒的「達菲」仿製品。
  6. No wonder generics firms are growing in confidence

    難怪仿製藥公司越來越有信心。
  7. Laboratory analysis can prove that the knockoff is chemically identical to the name - brand drug

    實驗室的分析可以證明仿製品的化學性質等同於品牌藥品。
  8. At a juncture when the global pharmaceutical industry is under siege for the prices it charges, hale and the 25 employees of oneworld have demonstrated that the spirit of the entrepreneur can be directed toward supplying something besides simple knockoffs of cholesterol and depression medication

    在全球制藥工業因索價昂貴而飽受攻訐的情況下，赫爾和天下一家的25名工作人員，證明創業的精神，可以朝向提供有用產品，而非僅止於單純仿製膽固醇和憂郁癥藥物。
  9. Now the scale of animal pharmaceutical trade is expanding and the quantity of animal pharmaceutical enterprise is increasing, all these will aggravate market compete. stiff competition due to less cost, small scope, low level and under - developed technology

    由於我國動物藥品業投入少，起點低，規模小，管理水平低，科研投入嚴重不足，產品技術含量普遍較低，多以仿製為主，產品競爭日趨白熱化。
  10. He favors requiring that prospective genericbiologic manufacturers test their drugs in humans before approval. hatch also supports establishing patient registries to track sideeffects that may not occur until years after patients start using aproduct

    他認為生物藥品仿製企業應該于獲批之前在人類身上試驗其產品，他還贊同建立病人登記制度以跟蹤調查病人用藥一年或幾年後的才發現的副作用。
  11. Genericsthat are chemical equivalents to conventional drugs save americans atleast $ 10 billion per year. the food and drug administration, however, lacks the legal ability to approve generic versions of biologics

    仿製藥為傳統藥物的化學等價物，它每年至少為美國人節省100億美元。而食品和藥物管理局缺乏相關的法律權能去批準生物藥品的仿製。
  12. Ranbaxy, a big indian generics firm, gobbled up six competitors last year and is now talking with private - equity firms about a bid for the generics arm of germany ' s merck

    印度仿製藥大廠南新去年一口氣吞掉了6個競爭者，目前正與私人股本公司洽談，以競標德國默克的仿製藥子公司。
  13. This price difference is largely due to the lack of generic competition in the second - line market : there are presently no generic versions of tfv and only one generic version of lpv r. there are generic versions of enterocoated ddi, but they are not available in south africa and many other countries. the manufacturer bristol - myers squibb has refused to include enterocoated ddi in its differential pricing policy, making the drug much more expensive

    這個價格差異，是因為第二線藥物?場缺乏仿製藥的競爭：泰諾福韋目前尚未有仿製藥，洛匹那韋利托那韋只有一種仿製藥，地丹諾辛的腸溶劑型則在南非及許多國家找不到仿製藥，加上原創藥廠拒絕把地丹諾辛的腸溶劑型納入其差別定價的政策之內，令該藥價格更高。
  14. At present, very few clinical trials are conducted in children, partly because obtaining “ informed consent ” is hardly possible. ( the who hopes that countries can at least compare notes on how to get round that problem. ) this in turn deters pharmaceutical firms from researching and developing child - friendly medicines, and generic drug producers from producing low - cost versions

    現在很少有臨床試驗是針對兒童的，部分原因是因為「告知同意」原則很難遵守（ who希望各國能夠想辦法繞過這個問題） ，這也給制藥企業研發兒童用藥，非專利藥製造商生產廉價的仿製藥製造了障礙。
  15. He sees his firm becoming one of the world ' s top producers of generic drugs within five years

    辛格見證了南新公司五年間成為了世界最大的仿製藥廠商之一。
  16. As they are often made by generic companies, fdcs are also generally much cheaper than the single pills sold by originator companies

    這種藥物通常是仿製藥，由仿製藥廠製造，故價格亦比原創藥廠所製造的便宜得多。
  17. The global generic - drugs market is worth nearly $ 60 billion and well over half its pills and potions are sold in america and britain, reckons ims health, another consultancy

    據艾美仕咨詢公司估計，全球仿製藥市場價值近600億美元，半數的藥品銷往美國和英國。
  18. American firms, including pfizer and merck, are trying to launch their own “ authorised generics ” a few months before patents expire to try to blunt the impact of competition

    包括輝瑞和默克在內的美國公司試圖在專利到期前幾個月推出自己的「授權仿製藥」 ，以減輕仿製藥帶來的競爭影響。
  19. This week it confirmed it approved a cheap, copycat version of a blockbuster heart disease medication - the first time a developing country has torn up the international patent for treatments like this - and a generic version of an aids drug

    這周他們宣告一鳴驚人信息，說成功研發出了一種廉價的治療心臟疾病的仿製藥物- -這是發展中國家第一次撕碎國際專利特權- -並生產出愛滋病普通仿製藥。
  20. But the generic - drug business is fiercely competitive, and the key to success often is providing the least expensive product - - a pressure on prices that has allowed wal - mart to sell almost 200 generic drugs for a flat $ 4 - per - prescription fee

    但是仿製藥的競爭是非常激烈的，成功的關鍵往往是提供花費最少的產品?這種價格壓力已經導致沃爾瑪將出售的將近200種仿製藥每種只收4美元的處方費用。
分享友人
分享到 Line

分享到臉書